BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3588320)

  • 1. [Clinical results of immunoscintigraphy and radioimmunotherapy].
    Baum RP; Lorenz M; Senekowitsch R; Albrecht M; Hör G
    Nuklearmedizin; 1987 Apr; 26(2):68-78. PubMed ID: 3588320
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoscintigraphy with 99mTc marked melanoma antibody in patients with malignant melanoma].
    Rentsch M; Cerny T; Richner J; Brunner KW; Rösler H; Nachbur B
    Helv Chir Acta; 1989 Jun; 56(1-2):11-3. PubMed ID: 2777587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radioimmunoscintigraphy in experimental and clinical tumors].
    Dienstbier Z
    Cas Lek Cesk; 1991 Mar; 130(13):385-9. PubMed ID: 1868508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical results of immunoscintigraphy in a variety of malignant tumors with special reference to immunohistochemistry.
    Biersack HJ; Bockisch A; Oehr P; Knoblich A; Hartlapp J; Biltz H; Jaeger N; Bellmann O; Vogel J; Björklund B
    Nuklearmedizin; 1986 Oct; 25(5):167-71. PubMed ID: 3540857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoscintigraphy with 99mTc labelled F(ab')2 fragments of an anti melanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanoma.
    Cerny T; Owens SE; Mackenzie SA; Nuttall PM; Gosh AK; Smith DB; Thatcher N
    Eur J Nucl Med; 1987; 13(3):130-3. PubMed ID: 3622556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoscintigraphy of malignant melanoma].
    Nicol L; Sandron A; Herry JY; Chevrant-Breton J
    Pathol Biol (Paris); 1990 Oct; 38(8):866-9. PubMed ID: 2274393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioimmunoscintigraphy with monoclonal antibodies].
    Scheidhauer K; Landthaler M; Denecke H; Stefani FH; Schumacher U; Leinsinger G; Eiermann W; Moser E; Lissner J
    Digitale Bilddiagn; 1987 Sep; 7(3):134-40. PubMed ID: 3500011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoscintigraphy with radiolabeled antibodies: an overview of the progress and limitations.
    Salvatore M
    J Nucl Biol Med (1991); 1991; 35(1):21-3. PubMed ID: 1932172
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunoscintigraphy of tumors in clinical practice].
    Dvorák P
    Cas Lek Cesk; 1988 Dec; 127(49):1508-11. PubMed ID: 3219708
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoscintigraphy of tumours: possibilities and limitations.
    Pimm MV; Perkins AC; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):61-71. PubMed ID: 6332618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoscintigraphy with combinations of various monoclonal antibodies--studies on xenografts of human gastrointestinal carcinomas.
    Horstmeier U; Klapdor R; Bahlo M; Montz R
    Nuklearmedizin; 1988 Mar; 27(2):46-50. PubMed ID: 3163421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoscintigraphy with a technetium 99m-labeled monoclonal antibody in patients with melanoma].
    Dudczak R; Kletter K; Bailer H; Kokoschka E; Pohl-Markl H
    Wien Klin Wochenschr; 1987 Apr; 99(7):232-9. PubMed ID: 3590802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoscintigraphy. Development, current status and prospects].
    Baum RP; Hör G
    Nuklearmedizin; 1986 Oct; 25(5):157-61. PubMed ID: 3491975
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor localization techniques in radiation therapy.
    Cancer; 1976 Apr; 37(4 Suppl):2035-45. PubMed ID: 944087
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoscintigraphy with 123I, 99mTc and 111In-labelled F(ab')2 fragments of monoclonal antibodies to a human high molecular weight-melanoma associated antigen.
    Buraggi GL; Callegaro L; Turrin A; Cascinelli N; Attili A; Emanuelli H; Gasparini M; Deleide G; Plassio G; Dovis M
    J Nucl Med Allied Sci; 1984; 28(4):283-95. PubMed ID: 6535835
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic imaging of malignant melanoma with radiolabeled antitumor antibodies.
    Larson SM; Carrasquillo JA; Krohn KA; McGuffin RW; Williams DL; Hellström I; Lyster D
    JAMA; 1983 Feb; 249(6):811-2. PubMed ID: 6600501
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunoscintigraphic detection of metastasis in malignant melanoma in the head and neck area].
    Rosanowski F; Briele B; Walther EK
    Laryngorhinootologie; 1994 Feb; 73(2):94-7. PubMed ID: 8161416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical status of immunoscintigraphy with monoclonal antibodies in ocular melanoma.
    Schaling DF; Jager MJ; van Kroonenburg MJ; Oosterhuis JA; Pauwels EK
    Int J Biol Markers; 1991; 6(1):25-30. PubMed ID: 1856514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoscintigraphy in experiments and clinical practice: its possibilities, advantages and limitations].
    Svihovcová P; Koprivová H; Novák F; Dvorák P; Poucková P; Pospísil J; Seblová J; Dienstbier Z; Micheel B; Jantscheff P
    Bratisl Lek Listy; 1989 Oct; 90(10):740-3. PubMed ID: 2819486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoscintigraphy in tumour identification.
    Britton KE; Granowska M
    Cancer Surv; 1987; 6(2):247-67. PubMed ID: 3322547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.